About 30 results found for searched term "Angiotensin Receptor" (0.189 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M2105 | Azilsartan medoxomil | Angiotensin Receptor |
| TAK-491 | ||
| Azilsartan Medoxomil is an effective angiotensin II Type 1 (AT1) receptor antagonist that inhibits RAAS more than 10,000 times more selectively than AT2, and is used to study hypertension. | ||
| M2106 | Azilsartan | Angiotensin Receptor |
| TAK-536 | ||
| Azilsartan (TAK-536) is an angiotensin II type 1 (AT1) receptor antagonist with IC50 of 2.6 nM. | ||
| M2164 | PD 123319 ditrifluoroacetate | Angiotensin Receptor |
| PD 123319 ditrifluoroacetate is a potent, selective, non-peptide angiotensin AT2 receptor antagonist. | ||
| M2258 | Losartan potassium | Angiotensin Receptor |
| Cozaar | ||
| Losartan potassium is a selective non-peptide angiotensin AT1 receptor antagonist. | ||
| M2674 | Eprosartan Mesylate | Angiotensin Receptor |
| Futuran; Navixen | ||
| Eprosartan is a nonpeptide angiotensin II receptor antagonist, [3H]-eprosartan binds to the AT1 receptor with KD of 0.83 nM in rat vascular smooth muscle cells. | ||
| M3265 | Olmesartan | Angiotensin Receptor |
| Benicar, Olmetec | ||
| Olmesartan is an angiotensin II receptor antagonist with an IC50 of 7.7 nM. | ||
| M3275 | Irbesartan | Angiotensin Receptor |
| SR-47436; BMS-186295 | ||
| Irbesartan (SR-47436, BMS-186295) is a highly potent and specific angiotensin II type 1 (AT1) receptor antagonist with IC50 of 1.3 nM. | ||
| M3289 | Telmisartan | Angiotensin Receptor |
| BIBR 277 | ||
| Telmisartan is an angiotensin II receptor antagonist (ARB) used in the management of hypertension. | ||
| M3374 | Zolmitriptan | 5-HT Receptor |
| BW-311C90; 311C90 | ||
| Zolmitriptan is a 5-HT1B/1D-angiotensin receptor (5-HT1B/1D-AR) partial agonist with Ki's of 5.01 nM, 0.63 nM, and 63.09 nM for 5-HT1B, 5-HT1D, and 5-HT1F receptors, respectively.Zolmitriptan can be used in studies related to migraine. | ||
| M3503 | Candesartan | Angiotensin Receptor |
| CV 11974 | ||
| Candesartan is an angiotensin II receptor antagonist with IC50 of 0.26 nM. | ||
| M3507 | Valsartan | Angiotensin Receptor |
| CGP 48933 | ||
| Valsartan is an angiotensin II receptor antagonist with IC50 of ranging from 39.5 to 116 μM. | ||
| M3511 | Olmesartan Medoxomil | Angiotensin Receptor |
| CS 866 | ||
| Olmesartan Medoxomil is a compound which is hydrolyzed to olmesartan that is a selective AT1 subtype angiotensin II receptor antagonist. | ||
| M3790 | Tasosartan | Angiotensin Receptor |
| WAY-ANA 756 | ||
| Tasosartan is a selective, potent, orally active and long-acting nonpeptide Angiotensin II type 1 (AT1) receptor antagonist. | ||
| M3917 | PD 123319 | Angiotensin Receptor |
| (S)-(+)-PD 123319 | ||
| PD 123319 is a potent, selective AT2 angiotensin II receptor antagonist with IC50 of 34 nM. | ||
| M5731 | LCZ696 | Angiotensin Receptor |
| Sacubitril/Valsartan；Entresto | ||
| LCZ696, consisting of Valsartan and Sacubitril in a 1:1 molar ratio, is a first-in-class dual-action angiotensin receptor-neprilysin inhibitor (ARNi,angiotensin receptor-neprilysin inhibitor) for the study of hypertension and heart failure. | ||
| M6240 | Angiotensin II human | Animal Modeling |
| Angiotensin II; Hypertensin II; Ang II; DRVYIHPF | ||
| Angiotensin II human is converted by Angiotensin I through removal of two C-terminal residues by the enzyme angiotensin-converting enzyme (ACE). Angiotensin II is mediated by AT1 and AT2 receptors, which are seven transmembrane glycoproteins with 30% sequence similarity. Keep away from light and prepare for use now. | ||
| M7675 | BMS-248360 | Others |
| BMS-248360 is an orally active dual antagonist of angiotensin II subtype 1 (AT1) and endothelin subtype A (ETA) receptors. | ||
| M9056 | Losartan | Angiotensin Receptor |
| DUP-89 | ||
| Losartan is an angiotensin II receptor antagonist, competing with the binding of angiotensin II to AT1 receptors with IC50 of 20 nM. | ||
| M9852 | BIBS39 | Angiotensin Receptor |
| BIBS-39; CS-2534 | ||
| BIBS39 is a new nonpeptide angiotensin II (AII) receptor antagonist. | ||
| M10146 | TRV-120027 TFA | Angiotensin Receptor |
| TRV027 TFA | ||
| TRV-120027 (also known as TRV027) is an angiotensin II receptor type 1 (AT1R) antagonist and engages ß-arrestins while blocking G-protein signaling. | ||
| M10273 | AVE 0991 | Angiotensin Receptor |
| AVE0991; AVE-0991 | ||
| AVE 0991 is an orally active agonist of angiotensin-(1-7) receptor with IC50 of 21 nM. | ||
| M13903 | Angiotensin II (3-8), human TFA | Angiotensin Receptor |
| Angiotensin II (3-8), human (TFA) is a less effective agonist at the angiotensin AT1 receptor. | ||
| M13907 | AT2 receptor agonist C21 | Angiotensin Receptor |
| AT2 receptor agonist C21 is a druglike selective angiotensin II AT2 receptor agonist with Ki values of 0.4 nM and >10 µM for the AT2 receptor and AT1 receptor, respectively. | ||
| M13909 | CGP-42112 | Angiotensin Receptor |
| CGP42112A | ||
| CGP-42112 (CGP-42112A) is a potent Angiotensin-II subtype 2 receptor(AT2 R) agonist. | ||
| M13910 | Eprosartan | Angiotensin Receptor |
| SKF-108566J free base | ||
| Eprosartan (SKF-108566J free base) is a selective, competitive, nonpeptid and orally active angiotensin II receptor antagonist, used as an antihypertensive. | ||
| M13912 | Fimasartan | Angiotensin Receptor |
| BR-A-657 | ||
| Fimasartan(BR-A-657) is a non-peptide angiotensin II receptor antagonist used for the treatment of hypertension and heart failure. | ||
| M13914 | ZD 7155(hydrochloride) | Angiotensin Receptor |
| ZD 7155 hydrochloride is an angiotensin II receptor type 1 (AT1 receptor) antagonist. | ||
| M20689 | Sparsentan (RE-021) | Endothelin Receptor |
| PS-433540; RE-021; DARA-a; BMS-346567 | ||
| Sparsentan (PS-433540, RE-021, DARA) is a first-in-class, orally active, high-affinity dual antagonist of the endothelin type A receptor (ETA) and Angiotensin II type 1 (AT1) receptor, with Ki values of 9.3 and 0.8 nM, respectively. | ||
| M27752 | TD-0212 | Angiotensin Receptor |
| TD-0212 (compound 35) is an orally active dual pharmacology angiotensin II type 1 receptor (AT1) antagonist and neprilysin (NEP) inhibitor, with a pKi of 8.9 for AT1 and a pIC50 of 9.2 for NEP. | ||
| M27753 | TD-0212 TFA | Angiotensin Receptor |
| TD-0212 TFA is an orally active dual pharmacology angiotensin II type 1 receptor (AT1) antagonist and neprilysin (NEP) inhibitor, with a pKi of 8.9 for AT1 and a pIC50 of 9.2 for NEP. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
